The Effect of Nordic Walking for Improving Walking Ability in Patients with Peritoneal Dialysis : a Randomized Controlled Trial
- Conditions
- Patients with peritoneal dialysis
- Registration Number
- JPRN-UMIN000052466
- Lead Sponsor
- Japanese Red Cross Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Not provided
1)Patients who are contraindicated for exercise training. Concrete criteria are as follows: patients with uncontrolled persistent hypertension (systolic blood pressure >= 180 mmHg or diastolic pressure >= 110 mmHg); severe anemia (Hb < 7 g/dL); active proliferative diabetic retinopathy; prior symptomatic coronary artery or cerebrovascular diseases within the previous 3 months; uncontrolled heart failure (NYHA >= III); symptomatic or lethal arrhythmia; severe valvular diseases; and walking difficulty due to orthopedic, cerebrovascular and peripheral artery diseases. 2) Unstable PD patients. Concrete criteria are as follows: patients who undergo PD less than 3 months and those with uncontrolled uremia (BUN > 100 mg/dL, K > 6.0 mEq/L and HCO3 < 18 mmoL/L). 3) Patients deemed inadequate for monitoring during study period, as determined by investigators.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Six-minute walk test as an index of aerobic capacity in 12 weeks after assignment.
- Secondary Outcome Measures
Name Time Method Evaluation factors of sarcopenia (walking speed, grip strength, and skeletal mass index), ABI/PWV, body composition index, CKD-related parameters (serum Na/K/Cl, Ca/P/PTH intact, UA, TC/HDL/TG, Hb, carnitine), residual kidney function, Numerical Rate Scale of locomotor, evaluated 12 weeks after assignment.